You’re interested in addressing volume loss, fine lines, or expression lines but you don’t want to look overdone or altered.
You’ve avoided conventional fillers because you’ve seen results that read as artificial, or that made underlying structure look worse over time.
You’re drawn to treatments that work with your own biology rather than adding synthetic material to your face.
You want a physician-led strategy not a menu of injectables handed off to whichever provider is available that day.
You’re thinking about aesthetic care as part of your broader health picture, not a separate track of cosmetic procedures.
You want an honest conversation about what injectables can and can’t do, and how they fit alongside regenerative and internal-health strategies.
Most aesthetic practices lead with hyaluronic acid fillers and calcium hydroxylapatite to add immediate volume. Those products can produce genuine improvement, but they also carry trade-offs when overused such as tissue stretching, loss of natural facial proportions, and results that can compound unnaturally over years of repeat treatment.
Halo’s approach inverts the sequence. Where appropriate, we lead with regenerative injectables that support the skin’s own structural repair like allograft adipose matrix for volume, platelet-rich fibrin for collagen and elastin stimulation.
We still use modern neurotoxins like Dysport for expression lines, because they’re a well-studied, short-duration tool that doesn’t carry the same cumulative trade-offs.
The emphasis throughout is preservation, and a refreshed face that feels like you. Injectables at Halo are used to support its natural structure, never to override it.
Renuva is an allograft adipose matrix: donated, aseptically processed human fat tissue that has been prepared to retain the extracellular scaffold (collagen, growth factors, and matrix proteins) without the cellular content.
When injected into areas of volume loss, the matrix signals your body to generate new adipose tissue in its place. Histologic studies have documented new fat cell formation, angiogenesis, and tissue remodeling within weeks to months of treatment.
Unlike hyaluronic acid fillers, which gradually break down and require ongoing re-treatment, Renuva’s results are biological: the new fat tissue your body generates within the matrix can persist for years, similar to autologous fat grafting but without requiring a donor site or surgical harvest.
It’s used for volume restoration in the cheeks, temples, nasolabial folds, hands, and other areas where aging-related fat loss has occurred.
PRF is a second-generation platelet concentrate prepared from a small sample of your own blood. Compared to platelet-rich plasma (PRP), PRF uses a slower, single-spin centrifugation that forms a three-dimensional fibrin scaffold, which traps platelets and white blood cells and releases growth factors more gradually, over a period of roughly two weeks.
Injected into the dermis, PRF stimulates collagen production, improves skin texture, and addresses fine lines and periorbital hollowing.
Published clinical studies have documented measurable improvements in skin texture, fine lines, and patient-reported outcomes with injectable PRF protocols. Results typically develop gradually over weeks to months and often pair well with microneedling or laser therapy.
Dysport (abobotulinumtoxinA) is an FDA-approved neurotoxin used to temporarily soften dynamic expression lines, the wrinkles that form with repeated facial movement, particularly between the brows (glabellar lines), across the forehead, and around the eyes. Like other neurotoxins in its class, Dysport works by temporarily reducing the targeted muscle’s contraction signal, allowing overlying skin to smooth.
In Phase III clinical trials, Dysport has demonstrated rapid onset, median time to effect of approximately two days, with favorable safety and efficacy profiles. Results typically last three to four months, after which the treatment gradually wears off and can be repeated as indicated.
Our approach with neurotoxins emphasizes conservative dosing, preservation of natural expression, and treatment calibrated to your face, not a standardized protocol. Overuse of neurotoxins, particularly in patients who start young or receive high-dose treatment on compressed schedules, carries its own trade-offs. We’re candid about those.
For transparency: there are patients and presentations where hyaluronic acid fillers or calcium-based volumizers are the right answer. When that’s the case, we discuss them openly. But we don’t default to them, and we don’t recommend them to patients where a regenerative approach or a more conservative plan is likely to serve them better over time.
The same judgment applies to trend-driven injectable protocols such as high-volume cheek filling, dramatic chin and jawline augmentation, lip modification far beyond natural proportions.
These can produce striking short-term change. They can also, over years, reshape the underlying structure of the face in ways patients often regret. We’re suspicious of certainty sold where the long-term evidence is thin.
Injectables address visible symptoms of facial aging. They don’t address the drivers. Hormonal shifts, metabolic dysfunction, chronic inflammation, sleep disruption, nutritional gaps, and cumulative sun exposure all shape how your face ages and how well it responds to treatment.
Aesthetic care at Halo is not a separate track from hormone, metabolic, and longevity care, it is an extension of it. Addressing the internal drivers alongside the external treatment is what produces durable results, and it’s why we think about injectables as one tool within a broader strategy rather than as a standalone service.
Injectable planning at Halo starts with a consultation that examines what’s actually driving the concerns you want to address including volume loss, fine lines, texture changes, or expression patterns and whether injectables are the right tool or whether a different regenerative approach fits better.
When injectables are indicated, treatment is usually staged:
The sequencing matters. It lets us evaluate what each treatment is actually contributing, and avoids the compounding effects that come from stacking injectables without reassessment.
Framed honestly, injectables at Halo are a thoughtful, physician-led set of tools, deployed selectively within a broader aesthetic and health plan, not as a shortcut around fundamentals.
If you’re considering injectables but wary of looking overdone, or if you’ve had treatments elsewhere that didn’t feel like the right fit, the right first step is a clinical evaluation, not another injection stacked on an unclear plan.
Book a complimentary skin health consultation with AI-based imaging analysis to see what’s actually happening in your skin, and to discuss whether injectable treatments, alone or alongside other regenerative strategies, fit your goals.
Regenerative injectables and modern neurotoxins are generally well tolerated when delivered by trained physicians. Common, self-limiting effects include mild swelling, bruising, or tenderness at injection sites for several days after treatment, brief redness or small firm nodules that typically resolve on their own, and occasional transient headache following neurotoxin treatment. Renuva treatment areas are gently massaged for several days after injection per protocol, and patients are advised to avoid pressure or friction over the treated area during that window. Dysport results typically emerge over two to seven days, so patience is part of the plan.
Contact the clinic if swelling, bruising, or tenderness worsens rather than improves after 48 to 72 hours, if unusual skin changes, firm lumps, or pigmentation changes develop, or if you notice any new symptom you’re uncertain about. Seek urgent care immediately for signs of infection at a treatment site (spreading redness, warmth, fever), sudden severe pain, vision changes, facial weakness beyond the treated area, difficulty swallowing or breathing, or any symptom that feels clinically concerning.
Regular fillers, hyaluronic acid, calcium hydroxylapatite, physically occupy space in the tissue and gradually break down over months to a year or two. Renuva is an adipose matrix that signals your body to generate its own new fat tissue in the treated area. The result is your own biology, not a synthetic or temporary substance, and the durability can be meaningfully longer.
They’re related but not the same. PRP (platelet-rich plasma) is a first-generation platelet concentrate. PRF (platelet-rich fibrin) uses a slower, single-spin centrifugation that creates a three-dimensional fibrin scaffold, which releases growth factors more gradually, over about two weeks and is generally thought to produce more sustained regenerative stimulation.
Dysport: onset typically within two to seven days, full effect by about two weeks, lasting three to four months. PRF: texture and tone improvements develop over several weeks to a few months and benefit from a series. Renuva: initial volume is visible immediately, but the biological remodeling and durable result develop over three to six months as new tissue forms.
Often, yes. PRF pairs well with microneedling or laser therapy. Renuva addresses volume loss that Sofwave or laser resurfacing can’t. Dysport complements regenerative treatments by softening the dynamic lines that continue to form even as skin quality improves. Sequencing matters, and that’s part of the planning conversation.
They’re in the same class of medications (both botulinum toxin type A) and work through the same mechanism. There are small differences in onset, spread, and dosing units, which is why we use whichever is best suited to the specific treatment area and patient.
Not when used conservatively and for the right indications. The “fake” look most patients want to avoid typically results from over-volumization, aggressive dosing, or frequent re-treatment without reassessment, none of which is our approach. Our goal is refinement, not transformation.
Generally, yes, when delivered by experienced physicians in a medically supervised setting. Regenerative treatments like Renuva and PRF have favorable safety profiles in clinical studies. Dysport has a long-established safety profile across Phase III trials and widespread clinical use. As with any injectable, there are specific risks and contraindications that we discuss before treatment.
Dysport: every three to four months while the effect is actively desired. PRF: typically a series of three treatments spaced monthly, with maintenance one to two times per year. Renuva: initial treatment may be followed by a touch-up at twelve weeks, with results persisting meaningfully longer than conventional filler.
You may also want to read about PRP, Microneedling, Sofwave Skin Lifting, Laser Therapy, and Hormone Optimization since these areas often overlap with facial aging and the internal factors that shape how your skin ages.
Medically Reviewed By: Halo Concierge Health
Halo Concierge Health is located in Raleigh, NC and serves practice members throughout North Carolina and Virginia. These areas include but are not limited to Raleigh, Wake Forest, Durham, Chapel Hill, Cary, Morrisville, Apex, Holly Springs, Fuquay-Varina, Garner, Clayton, Rolesville, Zebulon, and Mebane with options for follow-up telemedicine appointments.